Athira Pharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.1548 | 33.49 | -100.46% | -11.64 | -98.67% |
| P/S |
|
0 | 129.83 | -100% |
|
|
| P/BV |
|
0.5035 | 260.15 | -99.81% |
|
|
| P/FCF |
|
-0.1544 | -180.12 | -99.91% |
|
|
| Ev/Ebitda |
|
0.2568 | -28.84 | -100.89% |
|
|
| Ev/S |
|
0 | 548.04 | -100% |
|
|
| Ev/FCF |
|
0.2535 | -289.87 | -100.09% |
|
|
| E/P |
|
-6.46 | 0.0228 | -28467.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -375.54 | -100% | 0 | 0% |
| ROE |
|
-110.77 | 106.63 | -203.89% |
|
|
| ROA |
|
-88.52 | -2.32 | 3723.46% |
|
|
| ROIC |
|
-20.15 | 0.8343 | -2515.28% |
|
|
| ROS |
|
0 | -298.59 | -100% |
|
|
| ROCE |
|
-216.19 | 3.17 | -6914.58% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0127 | 0.9426 | -101.35% | -0.0144 | -11.73% |
| Nеt Debt/Ebitda |
|
0.492 | 1.04 | -52.89% |
|
|
| Debt/Ratio |
|
0.0207 | 0.1798 | -88.48% |
|
|
| Debt/Equity |
|
0.3108 | 1.62 | -80.81% |
|
|
| Debt/Net Income |
|
-0.0126 | -1.65 | -99.24% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5317 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8182 | -100% | ||
| DSI |
|
0 | 0.2062 | -100% |
|
|
| Average dividend growth |
|
0 | 2.29 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5169 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.77 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5317 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -99.58 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
413.92 | -152.61 | -371.23% | ||
| Growth impulse Net Income in 5 years |
|
384.7 | -115.25 | -433.8% | ||
| Growth impulse FCF in 5 years |
|
273.86 | -161.2 | -269.89% | ||
| Growth impulse EPS in 5 years |
|
1408.49 | -106.31 | -1424.89% |
IP Score
4.6/10
